Try our Advanced Search for more refined results
Health - March, 2011
292 articles
- J&J Judgment In Stent Patent Suit Climbs To $593M
- Cephalon Investor Sues Over $5.7B Valeant Bid Rebuff
- FDA Panel Calls For More Study On Food Dyes, ADHD
- Coventry Shareholder, ERISA Suits Trimmed
- NY Court Revives Medicor Claims Against UBS Units
- Actavis Pays $10M To Exit Kentucky Medicaid Suit
- US Joins Rural/Metro Ambulance Services FCA Suit
- Judge Lets Yaz Counterclaims Against Bayer Stand
- Agencies Assemble Antitrust Guidance For ACOs
- Swisslog Prevails In McKesson Drug Dispenser IP Suit
- WilmerHale Snatches Howrey, Munger Tolles IP Attys
- Aventis Settles Suit Over Allegra Patent
- Judge Nixes Dismissal Bid In Thalomid Antitrust Suit
- Biolitec Laser Doesn't Infringe AMS Patent: Judge
- Medtronic Didn't Infringe BSC Defibrillator IP: Judge
- GSK Gets $3.5M Verdict In Norvir Antitrust Case
- FDA Weighs Testimony On Health Risks Of Food Dyes
- CDC Probes Bacteria Outbreak From Contaminated IVs
- DC Resident's FCA Claims Killed In Vioxx Fight
- Sanofi Can't Nix Shareholder Suit Over Zimulti
- Novartis, Elan Sue IPC Over Generic Focalin XR
- Generics Makers Ask High Court For State Law Shield
- Pronova, Apotex Strike Deal Over Generic Lovaza
- Paxil Suits Remanded To State Court, To GSK's Chagrin
- Sonova Execs Resign Amid Insider Trading Probe
- Implications Of Nickerson V. Stonebridge
- Sullivan & Cromwell Reps Valeant In $5.7B Cephalon Bid
- Lannett Loses Bid To Enforce Celgene Oral Agreement
- Prosthetics Maker Can't Dodge Antitrust Claims
- Elan, Abbott Settle With Lupin Over Generic TriCor
- J&J Recalls Tylenol Products Amid Odor Concerns
- SEC Says FDA Chemist Made $3.6M In Insider Trading
- Fed. Circ. Fines Sun, Caraco Attys In Eloxatin IP Case
- Pfizer Subsidiary Recalls Mislabeled Drugs
- ProMedica Merger In Ohio Blocked Over Antitrust Fears
- Apotex Must Return $28M Award To Servier: UK Court
- Judge Rules Generic Drug Infringes Dermalogix Patent
- Feds Add Wire, Tax Fraud To Espada Corruption Charges
- Va. AG Tells 4th Circ. Entire Health Care Law Must Go
- Chattem To License LecTec Patch Patents For $3.6M
- FTC OKs $76M Astellas-Maxygen Protein Program Deal
- High Court Kills County's Drug Price Class Action
- An Ounce Of Prevention For Problems With No Cure
- NLRB's Shakeup Of Health Care Bargaining Units
- Cephalon Loses Bid For Quick Win In Marketing Suit
- Merck To Pay $4.2M To End Wis. Medicaid Fight
- Pfizer Beats False Marking Claims
- High Court Seeks US' View In Prandin Use Code Case
- Valuing Noncompetes: The Bradford Decision
- Drugstore.com Investor Fights $409M Walgreen Deal
- Fed. Circ. Revives Watson Challenge Of Seasonique IP
- CORRECTED: FTC OKs Quest's $740M Buyout Of Athena
- Class Rep Pushes To Kill Deal Over Chemo Drug Sales
- Purdue Sues Watson Over Generic OxyContin
- DOJ Expands Blue Cross Blue Shield Antitrust Probe
- Ex-Solicitor General To Rep States In PPACA Fight
- Medtronic Unit Must Face Antitrust Claims: Judge
- Fla. House Committee OKs Malpractice Cap Bill
- NY Commission Won't Probe Conflict In Medicaid Panel
- False Marking Law Found Constitutional In GSK Case
- Wyeth Takes $58M Loss In Hormone Case To High Court
- Group May Make Rival Bid For St. Vincent Facility
- Howmedica Asks High Court To Weigh Polymer IP Case
- 2nd Circ. Affirms Suntrust Win In Defamation Suit
- Cephalon Wins IP Suit Over Watson's Generic Fentora
- Par Sues UCB Over Generic Keppra
- Drug Sales Rep Sues Eisai Over OT Pay
- An Adverse Event For Statistical Significance
- $8.9M Nuvelo Class Action Deal Wins Preliminary OK
- Group Sues HHS For Access To Health Care Ad Info
- ITC Takes Up 337 Probe Of Merck's NuvaRing
- Vermont House Approves Single-Payer Health Care Bill
- Medtronic Unit Settles Faulty Spinal Implant Suit
- J&J Unit Yanks 360K Surgical Drain Products
- Solvay Wants Firms, Expert Removed In AndroGel Suit
- Senate Wants Quarterly Medicare Fraud Reports
- Fed. Circ. Nixes Apotex Appeal In Taxotere IP Fight
- FTC Drops Appeal Of LabCorp Merger Challenge
- Abbott Strikes Deal In Antitrust Battle Over HIV Drugs
- Medtronic, NuVasive Spinal Surgery IP Suit Continues
- 4 Views On Medical Device Preemption
- Jones Day Reps P&G in Joint Venture With Teva
- Sidley, Weil Rep Walgreen In $409M Drugstore.com Buy
- J&J Unit Downplayed Risperdal's Diabetes Link: Jury
- Terumo To Pay $35M Over Heart Device Violations
- Ex-GSK Atty Gets Indictment Over Wellbutrin Tossed
- Abbott, WARF End Zemplar Patent Suit Against Anchen
- Tenet Settles Class Action Over Katrina Deaths
- FTC Blesses Daiichi Sankyo's $805M Plexxikon Buy
- Va. AG Urges High Court To Take Up Health Care Suit
- HIG Picks Up Teleflex's Marine Biz For $122M
- Celera Investor Sues To Block $344M Quest Deal
- Utah University Sues Planck, MIT Over RNA Patents
- Takeda Sues Apotex Over Generic Actos
- Abbott Files New Simcor Patent Suit Against Teva
- HHS Sued Over Health Care Waiver Docs
- Targeting Health Care Antitrust In Texas
- Matrixx Opens Door For Plaintiffs, But Only A Crack
- Pfizer Unit To Exit Ch. 11 With $265M Asbestos Deal
- Watchdog Blasts Insurance Regulators' Industry Ties
- FTC Warns Miss. Lawmakers Over Drug Manager Bill
- Actavis Agrees To Hold Off On Generic Nuvigil
- BSC Can't Shake Contract Claim In Stent Patent Suit
- Sanofi, Merck Drop Animal Health Joint Venture
- Actonel Makers Launch 2nd Suit Over Mylan Generic
- Zuckerman Taps Buc & Beardsley FDA Pros
- Pros And Cons Of Statistical Sampling
- Indicted GSK Atty Says Prosecutors Misled Grand Jury
- Judge Asked To Toss Troutman Atty's Real Estate Suit
- Angiotech Seeks US Approval Of Canada Restructuring
- Holland & Knight Adds Ex-Pol To DC, Fla. Offices
- Female Bayer Workers Launch $100M Sex Bias Suit
- High Court Won't Hear Mylan IP Fight Over Benicar
- Camera-Pill Maker Triumphs In Endoscopy Patent Suit
- Morrison Ruling Doesn't Bar Elan ADR Suit: Judge
- 5 Marketing Lessons From Howrey's Graveside
- Duane Reade Escapes $7M Kasowitz Legal Fee Spat
- 1st Circ. Nixes NeuroMetrix Device Securities Suit
- Mylan Pushes FDA To Rule On Ranbaxy's Lipitor ANDA
- Tenn. Passes Law To Skirt Health Care Mandate
- Recall: Prevent, Manage, Mitigate And Survive
- Medco Sued Over CalPERS Bribery
- Coudert Settles Bard Unit's $25M Malpractice Claim
- Calif. Joins Relator's Kickback Suit V. Bristol-Myers
- Convicted Trader Protests SEC Penalty In 2nd Circ.
- US Sues Teva Over Generic HIV Drug
- SigmaPharm Appeals Skelaxin Antitrust, Contract Suit
- CDC Proposes New HIV Test Timeline For Organ Donors
- Nycomed Faces IP Suit Over Solaraze Gel
- Mich. Can't Sue Merck Over Vioxx, Appeals Court Says
- Orchid Can't Nix Roche Boniva Patent
- Labeling Gaffe Sparks Mylan Drug Recall In Canada
- US Fights Full 11th Circ. Review Of Health Care Law
- FDA Panel Pushes Menthol Cigarette Ban
- Defining The Essential Health Benefits Package
- Shearman Reps Quest Diagnostics In $344M Celera Buy
- Bayer Birth Control Patents Mostly Survive UK Suit
- Doctor Class Loses Cert. In Travelers Fraud Suit
- Insurer Hit With $19M Verdict Over Hospital Coverage
- FDA Head Takes $4.3B Budget Defense To Senate
- ITC Launches 337 Case Over Lilly's Gemzar Patent
- Understanding FTC V. LabCorp.
- The ABCDEFs Of Building Client Loyalty
- Minn. To Pay $7M To End HealthMatch Contract Row
- Class Counsel's Fees Halved In Fla. Insurance Suit
- Pfizer Unit Recalls Pain Drug Embeda
- HHS Readies Health Exchange Guidance For States
- Apotex Doesn't Infringe Provigil Patent, Judge Says
- Braintree Hits Amrutham With Laxative Patent Suit
- Mont. Orders AG To Join Health Care Reform Challenge
- Teva Exits Astellas Patent Suit Over Cancer Drug
- Tekmira Claims Alnylam Stole Gene Therapy Secrets
- Baxter Pockets Partial Costs In ERISA Win
- Triad Halts Production Of Pads Tied To Child's Death
- Premier Wins Bid To Arbitrate Rival's Antitrust Suit
- Endo Sues Mylan Over Generic Lidoderm Patch
- NY Assembly Challenges Cuomo's Malpractice Cap
- Cephalon Tries To Nix Approval For Generic Fentora
- Obama Accused Of Passing Health Law Regs In Secret
- 9th Circ. Refuses To Freeze $58M LabCorp Merger
- House Bill Would Ax Medicare Bidding Program
- Alnylam, German Group Settle RNA Patent App Case
- Latham Reps DJO In $254M Dr. Comfort Acquisition
- Gilead, Roche Sue To Block Generic Tamiflu
- IP Official Recommends Stronger Enforcement Plan
- DOJ Contests Va. Health Care Law Appeal
- Pa. Action Over Dead Health Care Plan Targets Pols
- Rite Aid Managers Take OT Actions To 3rd Circ.
- AstraZeneca Says SC Seroquel Suit Is Money Grab
- Guatemalans Infected With Syphilis Want US To Pay
- Fed. Circ. Won't Revisit Abraxis Loss In Naropin Suit
- Ex-Exactech Director Avoids Prison In Kickback Case
- One For The 'Have Nots'
- Troubleshooting Calif.'s Health Benefit Exchange
- Ropes & Gray Lures Life Sciences Atty From Goodwin
- St. Vincent's To Sell Manhattan Hospital For $260M
- CORRECTED: Medline To Pay $91M Over Medicare Kickback Suit
- Watson Wins Invalidity Ruling On 2 Fentora Patents
- Aventis, Sandoz Drop Swords In Taxotere Patent Suit
- 11th Circ. Fast-Tracks Health Care Reform Fight
- 2nd Circ. Kills B&L Indemnity Bid, Not Defense Claim
- Minn. Pharmacy Class Suit Wrongly Remanded: 8th Circ.
- FDA Chief Backs $4.3B Budget In House Hearing
- A Shot In The Arm For Section 2 Enforcement
- Patients Sue Genzyme Over Fabrazyme Rationing
- J&J Unit Agrees To Stop Making Drugs At Pa. Plant
- Ex-WellCare Execs Plead Not Guilty To Medicaid Fraud
- Ex-KV CEO Gets 1 Month, $1M Fine For False Drug Marks
- HHS Proposes New State Health Care Waiver Rules
- UBS Touted Fraudulent Medicore Investments: Atty
- NY Legislators, Hospital CEOs Charged With Bribery
- EU Embryo Patent Ban Covers Stem Cells: Court Adviser
- Vista Dodges Bulk Of Ex-Worker's Medicaid FCA Suit
- Becton Asks Fed. Circ. To Chuck $5M Syringe IP Loss
- Merchant & Gould Adds Hatch-Waxman Guru To IP Team
- AstraZeneca Seeks To Block Ex-Consultant's Testimony
- AstraZeneca To Pay $69M To States Over Seroquel
- Judge Certifies Mass. Class In CVS False Ad Suit
- Not So Sweet 16
- Generics Maker Sues 3M In Skin Cream Row
- MedAssets Seeks Discovery Sanctions In Insurance Row
- NC Lawmakers Fail To Pass Health Care Law Protest
- Health Care Law Can Buffer Improper CMS Costs: GAO
- 7th Circ. Tosses Qui Tam Suit Over Wordy Brief
- NY Hospital Workers Win Class Cert. Over Meal Breaks
- American Capital Can't Nix Insurers' Heparin Suit
- Tort Reform Group Sees Conflict In Cuomo Panel
- Houston Medical Supplier Convicted Of $4.3M Fraud
- Allergan, Rivals Debate Competition Claims' Validity
- Child Deaths Not Linked To Vaccines: Japan Drug Panel
- BSC, St. Jude Reach Deal Over Sales Exec Noncompete
- Ex-Best Medical Workers Slip Cancer Therapy IP Suit
- FTC Clears Danaher's Beckman Buy But Hurdles Remain
- United Health Seeks To Revive $28M Insurance Claim
- Fla. Judge Backs Contract For Prescription Program
- Latham Reps Catalyst In $525M Walgreen Unit Buy
- State AGs Support Health Care Law At 4th Circ.
- Antitrust Risks For ACOs
- US Appeals Fla. Ruling Against Health Care Reform Law
- UnitedHealth, Lawmakers Bash $24B Humana Contract
- Arrow, J&J Liability Claims Preempted: 11th Circ.
- Kaiser Unit To Settle OT Class Action For $1.1M
- Guatemalan Syphilis Subjects Set Class Action Deadline
- FDA Warns Of Risks To Babies From HIV Drug Kaletra
- Fed. Circ. Kills Mylan's Prilosec Antitrust Claims
- FTC Blesses GTCR's $675M Purchase Of Sterigenics
- 200 NY Attorneys Back Cuomo's Malpractice Overhaul
- GSK Sales Reps Seek 9th Circ. Rehearing On OT Status
- Fueling The BPCI Debate
- Woman Pleads Guilty To Wheelchair Fraud Scheme
- Tennessee House Passes Bill To Curb PPACA Mandates
- Drugmakers Beat Price-Fixing Claims In Ca. Court
- BNY, Wells Fargo OK'd To Intervene In $21M Ponzi Deal
- German Court Affirms Void Of Medix Testing Patent
- Caremark Can't Ditch Contract Claims In Coventry Suit
- Gibson Dunn Reps Accuray In $277M Radiotherapy Deal
- Generics Co. Asks Fed. Circ. To Revive Fortican Claims
- Bovie, Medtronic Settle IP Suit Over Surgical Device
- Watson, Orchid Defenses Live In Generic Azilect Row
- AstraZeneca, Mylan Spar Over Prilosec Suit Dismissal
- High Court Denies Cert In Biopsy Tool Patent Suit
- Supreme Court Spurns Investigation Retaliation Case
- MoFo Reps Terumo In $2.6B Gambro Unit Deal
- Japan Halts Pfizer, Sanofi Pediatric Vaccines
- Maximizing Your Chance At Federal Dollars
- Top Court Refuses To Hear Pay-For-Delay Challenge
- Gov'ts Win Cert. In McKesson Price-Rigging Suit
- Texas Judge Won't Move Aso Bandage Patent Case
- Mylan, Others Hit With Class Action Over Painkillers
- Trial Date Set In Ex-NY State Sen.'s Corruption Case
- Blackstone Sues Taro For $6M In Unpaid Merger Fees
- Drug Supply Co. Fraud Suit Referred To Mediation
- Cephalon Bid For Apotex Docs Denied In Provigil Suit
- Occlutech Implants Don't Violate IP: Swedish Court
- Sterilizer Co. To Pay $20M In Medical Device Action
- Ex-Cyberonics CEO Defies Options Reports In 2nd Circ.
- Merck Must Face Unjust Firing Suit, 1st Circ. Rules
- UnitedHealth Hit With ERISA Class Action
- Group Sues For Access To Kagan Health Care Law Docs
- GOP Brings Back Medical Malpractice Reform Bill
- FDA To Up Topamax Warning Over Birth Defect Data
- Paul Hastings Reps Valitas In $250M Merger
- Ex-WellCare CEO, Others Charged With Medicaid Fraud
- Cigna Worker Launches $100M Sex Bias Action
- Immunizing Vaccine Manufacturers From State Claims
- Allergan Tries To Nix Breast Implant Marking Suit
- Merck Settles Trade Secrets Row Over Software
- Fla. Judge Stays Toss Of Federal Health Care Reform
- J&J's Ethicon Unit Reveals Surgical Suture Recall
- Blue Cross Slaps Hofstra, Hospital With Logo IP Suit
- Sens. Clash Over 1st-To-File Patent Plan
- Suit Against $3B EMS Sale Targets BofA Merrill Lynch
- McKesson Fights $212M Ariz. Fine Over Drug Prices
- Fulbright Picks Up 2 Litigators For LA Office
- Senate Probes New Tools For Medicare Fraud Fight
- Neuralstem Calls StemCells Patents 'Unenforceable'
- Insurers Freed From Tissue Donation Coverage Suit
- Shareholder Seeks To Halt $1.2B Clinical Data Sale
- FDA Cracks Down On Unapproved Cold, Cough Drugs
- Merck, Teva End Cancidas Patent Fight
- Calling For Clarity On Conflict Metals
- Astellas Sued Over Efforts To Block Generic Prograf
- Pay-For-Delay Deals Stay Under Wraps In Cephalon Suit
- FTC Gives Green Light To $1.25B CVS-Universal Deal
- Genentech Nears $2.6M Deal In IT Workers' OT Suit
- KemPharm Hits Shire With Antitrust Counterclaims
- NIH To Study Health Of BP Spill Cleanup Workers
- Allergan's Acadia Securities Sales Spark SEC Subpoenas
- Simpson Reps Daiichi Sankyo In $805M Plexxikon Buy
- GenMark Drops Suit Over Caliper Microfluidics Patents
- ClearCorrect Faces IP, Competition Suits Over Braces
- Issues In HIE Creation And Participation